首页 | 本学科首页   官方微博 | 高级检索  
     


Elotuzumab and dexamethasone for relapsed or refractory multiple myeloma patients: A retrospective study
Authors:Zachary Gross  Ashkon Rahbari  Eric Wirtschafter  Tanya M. Spektor  Kyle A. Udd  Sean Bujarski  Michael Ghermezi  Jason D. Nosrati  Aleksandra Vidisheva  Benjamin Eades  Gary Cecchi  Tina Maluso  Regina Swift  James R. Berenson
Affiliation:1. Institute for Myeloma and Bone Cancer Research, West Hollywood, CA, USA;2. James R Berenson, MD Inc, West Hollywood, CA, USA;3. Olive View‐UCLA Medical Center, Sylmar, CA, USA;4. Oncotherapeutics, West Hollywood, CA, USA;5. Michigan State University College of Human Medicine, East Lansing, MI, USA;6. University of Arizona College of Medicine, Tucson, AZ, USA;7. Northern California Hematology, Berkeley, CA, USA
Abstract:
Keywords:elotuzumab  multiple myeloma  relapsed/refractory
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号